Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May;44(2):223-244.
doi: 10.1016/j.iac.2023.12.009. Epub 2024 Feb 16.

Dietary Management of Eosinophilic Esophagitis

Alfredo Lucendo  1 , Marion Groetch  2 , Nirmala Gonsalves  3
Affiliations
Review

Dietary Management of Eosinophilic Esophagitis

Alfredo Lucendo et al. Immunol Allergy Clin North Am. 2024 May.

Abstract

Eosinophilic esophagitis (EoE) is a chronic immune-mediated food allergy-driven disease characterized by eosinophilic inflammation of the esophagus leading to symptoms of esophageal dysfunction. Prior studies have supported the key role of food allergen exposure as the main driver behind the etiopathogenesis showing that removal of food antigens can result in disease remission in both children and adults. These landmark studies serve as the basis for the rising interest and evolution of dietary therapy in EoE. This article will focus on the rationale for dietary therapy in EoE and provide helpful tools for the implementation of dietary therapy in practice.

Keywords: Diet; Dietary therapy; Dysphagia; Elimination diet; Eosinophil; Eosinophilic esophagitis; Food allergy.

PubMed Disclaimer

Conflict of interest statement

Disclosure N. Gonsalves: Consultant for AstraZeneca, Allakos, BMS, Sanofi-Regeneron; Speaking: Sanofi-Regeneron. M. Groetch: Received royalties from UpToDate and the Academy of Nutrition and Dietetics and consulting fees from FARE; Serves on the Medical Advisory Board of the International Food Protein-Induced Enterocolitis Syndrome Association as a Senior Advisor to FARE, as a Health Sciences Advisor for APFED, and is on the editorial board of the Journal of Food Allergy; and has no commercial interests to disclose. A. Lucendo: Consultant for Dr Falk Pharma and EsoCap.

References